1 August 1999 in The Journal of Immunology
Numerous cellular and biochemical abnormalities in immune regulation have been described in patients with systemic lupus erythematosus (SLE), including surface Ag receptor-initiated signaling events and lymphokine production. Because NF-κB contributes to the transcription of numerous inflammatory genes and has been shown to be a molecular target of antiinflammatory drugs, we sought to characterize the functional role of the NF-κB protein complex in lupus T cells. Freshly isolated T cells from lupus patients, rheumatoid arthritis (RA) patients, and normal individuals were activated physiologically via the TCR with anti-CD3 and anti-CD28 Abs to assess proximal membrane signaling, and with PMA and a calcium ionophore (A23187) to bypass membrane-mediated signaling events. We measured the NF-κB binding activity in nuclear extracts by gel shift analysis. When compared with normal cells, the activation of NF-κB activity in SLE patients was significantly decreased in SLE, but not in RA, patients. NF-κB binding activity was absent in several SLE patients who were not receiving any medication, including corticosteroids. Also, NF-κB activity remained absent in follow-up studies. In supershift experiments using specific Abs, we showed that, in the group of SLE patients who displayed undetectable NF-κB activity, p65 complexes were not formed. Finally, immunoblot analysis of nuclear extracts showed decreased or absent p65 protein levels. As p65 complexes are transcriptionally active in comparison to the p50 homodimer, this novel finding may provide insight on the origin of abnormal cytokine or other gene transcription in SLE patients.
1 March 1999 in Immunology Today
1 November 2000 in Molecular Medicine Today
1 September 2000 in Current Opinion in Rheumatology
MNMadhusoodana P. Nambiar
The fate of the lymphocyte is determined by integration of signals delivered after the binding of antigen to the surface antigen receptor, signals delivered by cytokines that bind to their surface receptors, and signals initiated after the engagement of other surface receptors, known as costimulatory molecules. The summation of this input determines whether the immune cell will become stimulated, ignore the signal (anergy), or die (apoptosis). Antigen-receptor signaling events are abnormal in lupus lymphocytes, manifested by increased calcium responses and hyperphosphorylation of several cytosolic protein substrates. Further down, at the gene transcription level, the activity of the nuclear factor κB is decreased. These events are underwritten by defective T cell receptor ζ chain expression, overexpression of the γ chain of the FcεRI that functions as an alternate of ζ chain, and decreased p65 -Rel A protein that is responsible for the inducible NFκB activity. Accumulated research data have enabled us to begin deciphering the molecular basis of the abnormal lupus lymphocyte and may lead to the development of new medicinal treatments for lupus.
18 January 2002 in Arthritis & Rheumatism
MNMadhusoodana P. Nambiar
+2
Objective T cells from the majority of patients with systemic lupus erythematosus (SLE) display antigen receptor‐mediated signaling aberrations associated with defective T cell receptor (TCR) ζ chain expression. The TCR ζ chain, a critical signaling molecule, exists in multiple molecular forms and membrane fractions with distinct functions in antigen‐mediated signaling processes. This study was undertaken to investigate the complete spectrum of expression of the different forms and distribution of the TCR ζ chain in SLE T cells. Methods T cells were isolated from 48 SLE patients and 21 healthy subjects. The expression of various forms of the TCR ζ chain was investigated by immunoblotting with specific antibodies. The lipid raft‐associated form of the ζ chain was determined by quantitating the solubilized ζ chain after disruption of the lipid rafts by cholesterol depletion using methyl‐β‐cyclodextrin. The distribution of the ζ chain was investigated by fluorescence microscopy. Results The phosphorylated 21‐ and 23‐kd forms and the detergent‐insoluble membrane‐associated form of the TCR ζ chain and alternatively spliced ζ chain were significantly decreased in SLE T cells. In contrast, major ubiquitinated forms of the ζ chain were increased in these cells. We also identified up‐regulation of a novel 14‐kd form of the ζ chain in SLE T cells. Resting SLE T cell membranes had an increased percentage of the residual membrane‐bound ζ chain in the lipid rafts. Fluorescence microscopy findings indicated that the residual ζ chain is more clustered on the cell membranes of SLE T cells. Conclusion These results suggest that, in addition to the 16‐kd form, expression of other molecular forms and fractions of the TCR ζ chain as well as its membrane distribution are abnormal in SLE T cells. Increased lipid raft association and surface clustering of the ζ chain may explain the molecular mechanisms underlying the signaling abnormalities in these cells.
1 May 2002 in Clinical Immunology